LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

Market Cap	3.85B -1.0%
Revenue (ttm)	910.98M -1.2%
Net Income	52.49M -14.0%
EPS	0.10 -14.0%
Shares Out	510.66M
PE Ratio	73.34
Forward PE	n/a
Dividend	0.02 (0.26%)
Ex-Dividend Date	Jun 24, 2025

Volume	3,911,100
Average Volume	4,372,957
Open	7.85
Previous Close	7.76
Day's Range	7.53 - 7.85
52-Week Range	7.53 - 11.85
Beta	0.31
RSI	27.56
Earnings Date	Aug 27, 2026

About SHE:002644

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,332
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002644

Financial Performance

In 2025, SHE:002644's revenue was 915.53 million, a decrease of -6.60% compared to the previous year's 980.23 million. Earnings were 49.21 million, a decrease of -18.08%.